Literature DB >> 7825619

Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol.

F L Levy1, B Adams-Huet, C Y Pak.   

Abstract

Evaluations of 1,270 patients with recurrent nephrolithiasis in an outpatient setting were analyzed for the purpose of updating the classification of nephrolithiasis. All but 4% had abnormal urinary biochemistry that placed them into one or more of 20 etiologic categories. A single diagnosis was documented in 41.3% of patients. The remaining 58.7% had more than one diagnosis. Hypercalciuric calcium (Ca) nephrolithiasis, encountered in 60.9% of patients, comprised six variants--absorptive hypercalciuria Type I and II, renal hypercalciuria, primary hyperparathyroidism, and unclassified hypercalciuria (renal phosphate leak and fasting hypercalciuria). Hyperuricosuria Ca nephrolithiasis (HUCN) and gouty diathesis (GD) accounted for 35.8% and 10.0% of patients, respectively. Distinguishing features were hyperuricosuria and normal urinary pH in HUCN, and normal urinary uric acid and low urinary pH (< 5.5) in GD. Hyperoxaluric Ca nephrolithiasis, occurring in 8.1% of patients, was subdivided into enteric, primary, and dietary variants. Hypocitraturic Ca nephrolithiasis affected 28% of patients in its idiopathic variant. Many of these patients' problems were probably dietary in origin, while some could have had incomplete renal tubular acidosis. Hypocitraturia due to renal tubular acidosis or chronic diarrheal syndrome affected only 3.3% of patients. Hypomagnesiuric Ca nephrolithiasis, infection stones, and cystinuria were uncommon, accounting for 6.8%, 5.9%, and 0.9% of patients, respectively. The acquired problem of low urine volume (< 1 L/d) was found in 15.3% of patients. The remaining 3.5% of patients were difficult to classify despite the presence of abnormal urinary biochemistry.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7825619     DOI: 10.1016/S0002-9343(99)80080-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  66 in total

1.  Evaluating the associations between urinary excretion of magnesium and that of other components in calcium stone-forming patients.

Authors:  Sanaz Tavasoli; Maryam Taheri; Fatemeh Taheri; Abbas Basiri; Fahimeh Bagheri Amiri
Journal:  Int Urol Nephrol       Date:  2018-12-04       Impact factor: 2.370

Review 2.  Genes in idiopathic calcium oxalate stone disease.

Authors:  H O Goodman; R Brommage; D G Assimos; R P Holmes
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

3.  Variations between two 24-hour urine collections in patients presenting to a tertiary stone clinic.

Authors:  Madhur Nayan; Mohamed A Elkoushy; Sero Andonian
Journal:  Can Urol Assoc J       Date:  2012-02       Impact factor: 1.862

Review 4.  Cystine growth inhibition through molecular mimicry: a new paradigm for the prevention of crystal diseases.

Authors:  Michael H Lee; Amrik Sahota; Michael D Ward; David S Goldfarb
Journal:  Curr Rheumatol Rep       Date:  2015-05       Impact factor: 4.592

5.  Evidence for epistatic interaction between VDR and SLC13A2 genes in the pathogenesis of hypocitraturia in recurrent calcium oxalate stone formers.

Authors:  Domenico Rendina; Gianpaolo De Filippo; Fernando Gianfrancesco; Riccardo Muscariello; Michele Schiano di Cola; Pasquale Strazzullo; Teresa Esposito
Journal:  J Nephrol       Date:  2016-09-17       Impact factor: 3.902

6.  Incidence of kidney stone disease in Icelandic children and adolescents from 1985 to 2013: results of a nationwide study.

Authors:  Vidar O Edvardsson; Solborg E Ingvarsdottir; Runolfur Palsson; Olafur S Indridason
Journal:  Pediatr Nephrol       Date:  2018-04-06       Impact factor: 3.714

7.  Differentiating calcium oxalate and hydroxyapatite stones in vivo using dual-energy CT and urine supersaturation and pH values.

Authors:  Yu Liu; Mingliang Qu; Rickey E Carter; Shuai Leng; Juan Carlos Ramirez-Giraldo; Giselle Jaramillo; Amy E Krambeck; John C Lieske; Terri J Vrtiska; Cynthia H McCollough
Journal:  Acad Radiol       Date:  2013-12       Impact factor: 3.173

Review 8.  Recent advances in the pathophysiology of nephrolithiasis.

Authors:  Khashayar Sakhaee
Journal:  Kidney Int       Date:  2008-12-10       Impact factor: 10.612

9.  Magnesium metabolism and its disorders.

Authors:  R Swaminathan
Journal:  Clin Biochem Rev       Date:  2003-05

10.  Metabolic risk factors and the effect of metaphylaxis in pediatric stone disease with hypocitraturia.

Authors:  Onur Karsli; Volkan Izol; I Atilla Aridogan; Ali Borekoglu; Nihat Satar
Journal:  Urolithiasis       Date:  2012-12-30       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.